Clinical Practice Guidelines
2.0.0 - STU2 International flag

Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions

ActivityDefinition: CHF LASIX PO Activity Defintion (Experimental)

Official URL: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-po Version: 2.0.0
Active as of 2024-11-26 Computable Name: CHFLASIXPO
Other Identifiers: OID:2.16.840.1.113883.4.642.40.48.11.29

Activity definition to administer LASIX PO as part of a congestive heart failure pathway

Generated Narrative: ActivityDefinition chf-lasix-po

CQF Knowledge capability: shareable

CQF Knowledge capability: computable

CQF Knowledge capability: publishable

url: ActivityDefinition CHFLASIXPO

identifier: Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.48.11.29

version: 2.0.0

name: CHFLASIXPO

status: Active

experimental: true

date: 2024-11-26 06:42:34+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

Activity definition to administer LASIX PO as part of a congestive heart failure pathway

jurisdiction: World

kind: MedicationRequest

profile: CPG Medication Request

code: Order a medication

intent: Proposal

priority: Routine

doNotPerform: false

product: LASIX PO

dosage

sequence: 1

text: 40mg

timing: Once per 1 days

route: Oral Route (qualifier value)

DoseAndRates

-TypeDose[x]
*Ordered40 mg (Details: UCUM codemg = 'mg')